The weekly litigation news digest is live. Subscribe now

IP Verse

Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization Lesion

Patent No. EP3230316 (titled "Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization Lesion") was filed by Bayer Healthcare on Dec 10, 2015. The application was issued on Jan 5, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AMGENOct 5, 2022UEXKULL & STOLBERG
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBBOct 5, 2022KUTTENKEULER
BOULT WADE TENNANTOct 5, 2022-
MAIWALDOct 5, 2022MAIWALD
WITHERS & ROGERSOct 4, 2022POHLMAN
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBOct 4, 2022WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3230316

BAYER HEALTHCARE
Application Number
EP15819965A
Filing Date
Dec 10, 2015
Status
Granted And Under Opposition
Dec 3, 2021
Publication Date
Jan 5, 2022
External Links
Slate, EP3230316B1, Google Patents